| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Ernexa Therapeutics Inc.
13D/A
ERNA · 114082308
|
34.7% |
2/17/2026
Event 2/10/2026
|
||||
|
Ernexa Therapeutics Inc.
13D/A
ERNA · 114082209
|
37.9% |
6/11/2025
Event 6/9/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.